Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dale Handley"'
Autor:
Alexandra C. Gillett, Saskia P. Hagenaars, Dale Handley, Francesco Casanova, Katherine G. Young, Harry Green, Cathryn M. Lewis, Jess Tyrrell
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background This study evaluates longitudinal associations between glycaemic control, measured by mean and within-patient variability of glycated haemaglobin (HbA1c) levels, and major depressive disorder (MDD) in individuals with type 2 diabe
Externí odkaz:
https://doaj.org/article/4df4c60fdfb84937bfcde5a0ecef070f
Autor:
Dale Handley, Sumaya Almansoori, Mitra S. Sato, Hasnat Amin, Suzanne Alsters, Harvinder Chahal, Sanjay Purkayastha, Kevin G. Murphy, Mieke van Haelst, Carel W le Roux, Tricia Tan, Robin G Walters, Fotios Drenos, Alexandra I Blakemore
IntroductionGlucagon-like peptide 1 (GLP1) agonists are highly effective agents for the treatment of obesity and type 2 diabetes (T2D). GLP-1 is also implicated in outcomes of bariatric surgery, including appetite changes and T2D remission. Rare, pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba25886d97049ba59a58afb498fad116
https://doi.org/10.1101/2023.05.22.23290347
https://doi.org/10.1101/2023.05.22.23290347
Autor:
Dale Handley, Mohammed Rafey, Sumaya Almansoori, John Brazil, Aisling McCarthy, Hasnat Amin, Martin O’Donnell, Alexandra Blakemore, Francis Finucane
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 11; Pages: 1881
Background: A better understanding of the influence of genetic factors on the response to lifestyle interventions in people with obesity may allow the development of more personalised, effective and efficient therapeutic strategies. We sought to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e4ee8f37944580ff381632f99f16ea
https://pubmed.ncbi.nlm.nih.gov/36579607
https://pubmed.ncbi.nlm.nih.gov/36579607